Status:
COMPLETED
HBV/HCV/HIV in Belgian Prisons
Lead Sponsor:
Hasselt University
Collaborating Sponsors:
University Ghent
Conditions:
Hepatitis C
Hepatitis B
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To assess the prevalence of blood-borne viral infections in prisons in Belgium, screening will be executed in several prisons in Flanders, Brussels and Wallonia to obtain a geographical representative...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Imprisoned in one of the predefined prisons in Flanders Brussels or Wallonia participating in this trial
- Written informed consent obtained
Exclusion
- Written informed consent not possible: (language barrier, illiteracy)
- Already participated in the study: re-entry within inclusion period in one of the prisons
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
3045 Patients enrolled
Trial Details
Trial ID
NCT04366492
Start Date
April 1 2019
End Date
March 31 2020
Last Update
April 29 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Gent
Ghent, Belgium, 9000
2
Hasselt University
Hasselt, Belgium, 3500